MANAGEMENT AND TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
    3.
    发明公开
    MANAGEMENT AND TREATMENT OF BENIGN PROSTATIC HYPERPLASIA 审中-公开
    供应和治疗良性前列腺增生症

    公开(公告)号:EP2214688A2

    公开(公告)日:2010-08-11

    申请号:EP08737763.6

    申请日:2008-04-08

    申请人: CSIR

    IPC分类号: A61K36/48 A61P13/08

    CPC分类号: A61K36/48

    摘要: The invention provides the use of an extract of a plant of the genus Elephantorrhiza and at least one compound selected from quercitin-3′-O-glucoside, trans-3-O-galloyl-3,3′,5,5′,7-pentahydroxyflavan, taxifolin-3′-O-glucoside, catechin and epicatechin in the preparation of a medicament for the treatment of benign prostatic hyperplasia (BPH). The mode of action is by a route selected from blocking the conversion of testosterone to dihydrotestosterone by inhibiting the 5α-reductase enzyme or by reducing oxidative stress or both.